April 12th, 2021
1:00 PM EST
Healthcare Litigation, Compliance & Enforcement Webinar Series
Healthcare industry leaders predict a drastic increase in enforcement actions stemming from the fallout of COVID and increased attention on policing fraud and abuse claims under the Biden administration, particularly claims related to CARES Act funds and increased use of telehealth during the public health emergency.
In our three-part webinar series, attendees will receive practical guidance from McDermott's white collar and healthcare lawyers, who have been studying the market to proactively advise clients on prioritizing compliance measures that providers, payors and life sciences companies need bolster in the face of increased enforcement activities. Each session will focus on a specific sector, giving attendees customized insights that will be pertinent for their business operations, and offering actionable tips on what to do should your organization receive a government subpoena.
___________________________________________________
Providers and Healthcare Enforcement in 2021: Biden, COVID-19 and FCA Updates Impacting Your Business
The large volume of relief funding distributed by the government in connection with the COVID-19 pandemic will be the source of enforcement and regulatory scrutiny for years to come. During this webinar – the first in a three-part series on healthcare enforcement, compliance and litigation in 2021 – our white collar and healthcare litigation partners will discuss the increased enforcement risks healthcare providers face in the post-COVID world and how the priorities of the new administration could affect them.
Some of the topics will include:
- Enforcement Policy: Early signals from the Biden administration and predictions for the future on:
- Provider Relief Fund investigations
- Telehealth enforcement
- Other COVID-19 relief programs and regulatory flexibilities
- Hot Issues in False Claims Act Litigation
- Objective Falsity: AseraCare vs. Care Alternative
- Escobar Materiality Update
- Testing the Limits of DOJ Dismissal Authority
SPEAKERS
